SCHEMBL3085279

SCHEMBL3085279

O=C1Nc2c(ccc(F)c2F)C1(O)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.41
POLB P06746 1/20 0.38
CASP6 P55212 1/20 0.38
KMT2A Q03164 6/20 0.36
MEN1 O00255 4/20 0.36
PIM1 P11309 1/20 0.33
MAPT P10636 4/20 0.32
NPSR1 Q6W5P4 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 2/20 0.31
MDM2 Q00987 1/20 0.31
MAPK1 P28482 1/20 0.31
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
ALOX12 P18054 1/20 0.30
TP53 P04637 2/20 0.30
CBX7 O95931 1/20 0.30
CDY1; CDY1B Q9Y6F8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3088677 0.78 GPR55 (0.50) POLBCASP6KMT2AMEN1MAPT
SCHEMBL3096324 0.77 POLB (0.48) BRD4POLBCASP6KMT2AALDH1A1
SCHEMBL24281158 0.73 KMT2A (0.44) POLBCASP6KMT2AMEN1
SCHEMBL5478134 0.71 POLB (0.41) BRD4POLBCASP6KMT2AMEN1
SCHEMBL3096321 0.71 POLB (0.47) BRD4POLBCASP6CES1
SCHEMBL3076584 0.71 PGR (0.33) POLBCASP6ALDH1A1LMNA
SCHEMBL3096028 0.70 POLB (0.37) BRD4POLBCASP6
SCHEMBL31184813 0.70 POLB (0.40) BRD4POLBCASP6KMT2AMEN1
SCHEMBL2497559 0.70 BRD4 (0.56) BRD4POLBCASP6KMT2AMEN1
SCHEMBL24281326 0.70 KMT2A (0.59) POLBCASP6KMT2AMEN1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
WO-2008129075-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE-COMPOUNDS TOPOTARGET A/S (DK) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TPH2, TPH1, HTR2C BRD4 616/4885POLB 2212/4885CASP6 2159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.